Literature DB >> 3485262

[Autoimmune antibody in moyamoya disease].

H Wanifuchi, M Kagawa, M Takeshita, M Izawa, S Maruyama, K Kitamura.   

Abstract

The association of autoimmune antibody and HLA antibody has been documented concerning the pathogenesis of moyamoya disease. In this paper, we study the autoimmune antibody in moyamoya disease and discuss its relationship with the pathogenesis. Autoimmune antibody was evaluated in 13 cases of moyamoya disease. The age distribution of the patients ranged from 13 to 55, with an average of 37 years. Eight were females, 5 males. Autoantibody was studied with native DNA (double strand DNA) and ANA (antinuclear antibody). Antibody was noted in 3 cases (23%) in native DNA study, and 2 cases (15%) in ANA study. Significantly high incidence was recognized compared with normal control (4%). In relation to the clinical features, such as initial symptoms, time of onset, neurological findings, no significant correlation was recognized. This study suggests that immunological factors might play a partial role in the pathogenesis of moyamoya disease.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3485262

Source DB:  PubMed          Journal:  No Shinkei Geka        ISSN: 0301-2603


  3 in total

1.  Dual anca positivity in a child with moyamoya-like cerebral vascular changes: an unusual presentation with sudden homonymous hemianopsia.

Authors:  Hale Sakalli; Esra Baskin; Füsun Alehan; Muhteşem Agıldere; Yonca Aydin Akova; Hakan Caner
Journal:  Rheumatol Int       Date:  2011-08-24       Impact factor: 2.631

Review 2.  A Better Understanding of Moyamoya in Trisomy 21: A Systematic Review.

Authors:  Arowa Abdelgadir; Hamna Akram; Maurice H Dick; Nabeel R Ahmed; Abanti Chatterjee; Sushil Pokhrel; Vaishnavi Vaijaya Kulkarni; Safeera Khan
Journal:  Cureus       Date:  2022-03-26

3.  Association of HLA-DQA2 and HLA-B With Moyamoya Disease in the Chinese Han Population.

Authors:  Jiang Wan; Wei Ling; Zhang Zhengshan; Zuo Xianbo; Duan Lian; Wang Kai
Journal:  Neurol Genet       Date:  2021-06-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.